Salvage lymph node dissection with adjuvant radiotherapy for Choline-PET-CT positive lymph node metastases in patients with nodal recurrence of prostate cancer

• Conditions: C61; C77; Malignant neoplasm of prostate; Secondary and unspecified malignant neoplasm of lymph nodes

• Registration Number: DRKS00003472
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05-29
• Study Completion: 2012-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 47

Inclusion Criteria

Patients with biochemical relapse after radical prostatectomy or primary radiotherapy, evidence (11C-choline or 18F-fluorethylcholin-PET-CT) for nodal recurrence of PCA , Charlson-Comorbidity-index = 2, age <80 years.

Exclusion Criteria

Presence of bone or visceral metastases, Charlson-Comorbidity-index > 2, age > 80 years, presence of untreated local recurrence in prostatic fossa, continuation of anti hormonal therapy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PSA-progression free survival

Secondary Outcome Measures

Name	Time	Method
clinical progression of prostate cancer<br>tumor specific and overall survival